|
|
Volumn 22 Suppl 4, Issue , 2007, Pages
|
|
Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical data.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANEMIC AGENT;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
BLOOD;
CHRONIC DISEASE;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
ECONOMICS;
HUMAN;
KIDNEY DISEASE;
PERITONEAL DIALYSIS;
PHARMACOECONOMICS;
RENAL REPLACEMENT THERAPY;
REVIEW;
ANEMIA;
CHRONIC DISEASE;
CLINICAL TRIALS;
ECONOMICS, PHARMACEUTICAL;
EPOETIN ALFA;
ERYTHROPOIETIN, RECOMBINANT;
HEMATINICS;
HUMANS;
KIDNEY DISEASES;
PERITONEAL DIALYSIS;
RENAL DIALYSIS;
RENAL INSUFFICIENCY, CHRONIC;
|
|
EID: 34547702814
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: 10.1093/ndt/gfm162 Document Type: Review |
|
Times cited : (23)
|
|
References (67)
|
